SCIENTIFIC ADVISORY BOARD

Professor Vasilis Ntziachristos PhD,

Professor Ntziachristos is the Director of the Institute for Biological and Medical Imaging (IBMI) at the Helmholtz Zentrum München and holds the Chair for Biological Imaging at the Technical University of Munich (TUM). Professor Ntziachristos has been active in the field of imaging since 1990 and joined TUM and the Helmholtz Association in 2007 from Harvard University where he served in the faculty ranks as an instructor and assistant Professor since 2000. Among numerous other awards, he was named in 2004 as one of the world’s top young innovators by the Massachusetts Institute of Technology (MIT) Technology Review and he received the European Research Council (ERC) Advanced Investigator award in 2008. He regularly chairs international meetings on Bio-optics and Molecular Imaging and he is an associate editor in Optics Letters and the IEEE Transactions of Medical Imaging – the top two imaging journals worldwide. He has 12 issued and pending patents (8 licensed) and he has successfully commercialized imaging technology in the past. Professor Ntziachristos is also a founder of the Company as well as a member of its Scientific Advisory Board.

Professor Gooitzen van Dam M.D. PhD,

Professor Van Dam is a Gastrointestinal and Surgeon Oncologist at the University Medical Center Groningen and the Director of the BioOptical Imaging Center Groningen. Professor Van Dam has been involved in the field of optical imaging and intra-operative cancer assessment for the past 10 years and has been applying molecular imaging methods for cancer imaging since 2002. He is an author in numerous scientific publications and he has been pivotal in identifying key molecular signatures that can lead accurate surgical procedures in patients.

Professor Eben Rosenthal, M.D.

Eben Rosenthal is a surgeon-scientist who is currently serving as the Ann and John Doerr Medical Director of the Stanford Cancer Center, a position he has held since July 2015. He oversees the clinical delivery of cancer care across Stanford Medicine and regional cancer networks. He is clinically active in microvascular reconstruction of complex head and neck defects. He has published over 160 peer-reviewed scientific manuscripts, authored many book chapters and published a book on optical imaging in cancer. He leads a multidisciplinary team of scientists that have successfully performed first in human clinical trials using fluorescently labeled antibodies in the clinic and operating room. These early phase clinical trials have demonstrated that fluorescence enhancement can visualize microscopic cancer in the operating room and may significantly improve clinical outcomes.

Hans-Christian Kolberg, MD

Since 2005 Dr. Kolberg is head of department for gynecology and obstetrics at the Marienhospital Bottrop, an academic teaching hospital for the University of Essen. He is also leading the multidisciplinary breast cancer center and gynecologic cancer center at his institution. Before 2005 he was a senior consultant and director of breast services at the University Hospital of Schleswig-Holstein, Campus Lübeck, where he lead the breast cancer center to the first accreditation by the EUSOMA in Germany in 2004. Besides his clinical work he also principal investigator for numerous clinical trials mainly regarding breast cancer and one of the spokesmen of the German Network of Certified Breast Cancer Centers. His scientific focus is the de-escalation of local and systemic breast cancer therapy.